Trelstar and Hilar lymphadenopathy - a phase IV clinical study of FDA data

Summary:

Hilar lymphadenopathy is reported as a side effect among people who take Trelstar (triptorelin pamoate), especially for people who are male, 60+ old, also take Zometa, and have Prostate cancer.

The phase IV clinical study analyzes which people have Hilar lymphadenopathy when taking Trelstar. It is created by eHealthMe based on reports of 1,489 people who have side effects when taking Trelstar from the FDA, and is updated regularly.

What is Trelstar?

Trelstar has active ingredients of triptorelin pamoate. eHealthMe is studying from 1,506 Trelstar users. Check the latest studies of Trelstar.

What is Hilar lymphadenopathy?

Hilar lymphadenopathy (disease of the lymph nodes due to infection) is found to be associated with 312 drugs and 314 conditions by eHealthMe. Check the latest studies of Hilar lymphadenopathy.

On Jul, 14, 2026

1,489 people reported to have side effects when taking Trelstar.
Among them, 13 people (0.87%) have Hilar lymphadenopathy.

Could Trelstar cause Hilar lymphadenopathy?

Among these 13 people:

What is the gender of people who have Hilar lymphadenopathy when taking Trelstar? *

female: 0.0 %
male: 100 %

What is the age of people who have Hilar lymphadenopathy when taking Trelstar? *

What are other drugs people take besides Trelstar? *

What are other side effects people have besides Hilar lymphadenopathy? *

Lymphadenopathy Mediastinal (an enlargement of the lymph nodes in the part of the chest that separates the lungs): 13 people, 100.00%
Pulmonary Embolism (blockage of the main artery of the lung): 12 people, 92.31%
Pathological Fracture (broken bone caused by disease): 12 people, 92.31%
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect): 12 people, 92.31%
Disability: 12 people, 92.31%
Injury: 12 people, 92.31%
Rotator Cuff Syndrome (a spectrum of conditions affecting the rotator cuff tendons of the shoulder): 12 people, 92.31%
Back Pain: 12 people, 92.31%
Pain In Extremity: 12 people, 92.31%
Aortic Arteriosclerosis (hardening of the aortic arteries): 12 people, 92.31%

What are the existing conditions these people have? *

Prostate Cancer: 7 people, 53.85%
Osteoporosis (bones weak and more likely to break): 4 people, 30.77%
Prostate Cancer Stage Iv: 1 person, 7.69%
Ankylosing Spondylitis (type of arthritis affecting the spine): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Trelstar and have Hilar lymphadenopathy?

- Check whether Hilar lymphadenopathy is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Trelstar:

Trelstar (1,506 reports)

Browse all side effects of Trelstar:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hilar lymphadenopathy:

Hilar lymphadenopathy (312 drugs)

Browse all the conditions that are associated with Hilar lymphadenopathy:

Hilar lymphadenopathy (314 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on triptorelin pamoate (the active ingredients of Trelstar) and Trelstar (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.